Determination of Dental Plaque Removal Efficacy: Testing Methods, Standards, and Applications | ZHONGXI Testing Italy,Global Testing and Certification Institute.

Dental plaque removal efficacy testing quantifies how effectively oral care products—including manual and powered toothbrushes, interdental cleaners, dentifrices, and mouthrinses—remove or inhibit the bacterial biofilm responsible for caries, gingivitis, and periodontal disease. Evaluations combine standardized in vitro brushing simulations with controlled clinical trials scored by internationally recognized plaque indices, in line with ISO 20126, ISO 20127, and related GB standards. This article explains the sample types, test items, methodologies, and practical applications of plaque removal efficacy determination performed by accredited third-party laboratories.

Technical Overview

Dental plaque is a structured biofilm of salivary pellicle and bacterial colonies that adheres tenaciously to enamel, cementum, restorations, and prosthetic surfaces. If not regularly and effectively disrupted, plaque mineralizes into calculus and triggers inflammatory processes that lead to gingivitis and, ultimately, periodontitis. Because consumers and regulators increasingly demand objective evidence for oral hygiene performance claims, manufacturers rely on quantitative efficacy determination before launching new products.

Plaque removal efficacy determination measures the ability of a device or formulation to reduce plaque coverage, plaque mass, or plaque regrowth under controlled, reproducible conditions. Testing is typically performed at two levels:

In vitro laboratory testing, which uses artificial plaque substrates, standardized brushing machines, and instrumental quantification to isolate the mechanical or chemical cleaning performance of a product.
In vivo clinical testing, which uses disclosed plaque scoring systems to evaluate real-world performance on human subjects under supervised protocols.

The principal international references include ISO 20126 (manual toothbrushes—general requirements and test methods), ISO 20127 (powered toothbrushes—general requirements and test methods), and their European adoptions as EN ISO standards. In China, national standards such as GB 19342 (toothbrushes) and GB 30002 (children's toothbrushes), together with the electrical safety requirements of the GB 4706 series for powered devices, frame the domestic compliance landscape. ISO 11609 covers requirements and test methods for dentifrices, whose anti-plaque performance is typically substantiated through controlled clinical studies.

Testing Samples

Manual Toothbrushes

Adult manual toothbrushes, children's toothbrushes, orthodontic brushes, multi-tufted designs, and tapered-filament brushes are evaluated for their ability to remove plaque from flat, interproximal, and subgingival surfaces. Sample submissions typically include production-intent finished brushes, brush heads, and reference brushes used as benchmarks.

Powered Toothbrushes

Rotating-oscillating, sonic, and ultrasonic toothbrushes, including replaceable brush heads of different stiffness and filament geometry, are tested for cleaning efficacy relative to a manual reference brush as described in ISO 20127. Battery life, brushing mode settings, and head oscillation parameters are documented as part of the test configuration.

Interdental Cleaning Devices

Dental floss, dental tape, interdental brushes, and oral irrigators (water flossers) are assessed for their capacity to disrupt plaque in interproximal contact areas and below the gingival margin—zones where conventional brushing is least effective.

Dentifrices and Mouthrinses

Anti-plaque toothpastes, gels, and mouthwashes containing active agents such as stannous fluoride, chlorhexidine, cetylpyridinium chloride, or essential oil blends are evaluated for chemical plaque inhibition and regrowth suppression rather than mechanical removal alone.

Emerging Oral Care Products

Chewing gums with plaque-control claims, antibacterial coatings on brush filaments, plaque-disclosing tablets and solutions, and novel cleaning devices can also be characterized through customized efficacy protocols.

Testing Items

Typical test items within a plaque removal efficacy program include:

In vitro plaque removal rate, expressed as the percentage of artificial plaque substrate removed after a defined brushing cycle.
Comparative cleaning efficacy against a reference toothbrush under identical brushing parameters.
Interproximal and gingival margin cleaning performance, targeting hard-to-reach anatomical zones.
Plaque coverage area reduction, quantified by digital image analysis or profilometric measurement.
Clinical plaque index reduction using the Turesky modification of the Quigley-Hein index, the Silness-Löe plaque index, or the Rustogi modification of the Navy plaque index.
Plaque regrowth inhibition over 24-hour or multi-day no-brushing periods for chemical agents.
Durability of cleaning performance after simulated wear, fatigue, or accelerated aging of brush heads.
Complementary safety-related determinations, such as filament end-rounding, tuft retention, and dentin abrasivity (RDA/REA), ensuring that plaque removal does not come at the cost of hard or soft tissue damage.

Testing Methods

In Vitro Brushing Simulation

Laboratory testing employs a standardized brushing machine that reproduces reproducible oral hygiene mechanics. A plaque-simulating substrate—composed of a defined artificial soil film—is uniformly applied to carriers such as glass slides, bovine enamel or dentin slabs, or hydroxyapatite discs. The specimen is then brushed under controlled parameters, typically including:

A constant contact force, commonly around 2.5 N.
A defined number of linear or rotary brushing strokes, or a fixed contact time for powered devices.
A controlled temperature and, where relevant, a standardized dentifrice slurry.

Residual substrate is quantified gravimetrically, by digital planimetric image analysis, or by surface profilometry. Plaque removal efficiency is calculated as the ratio of substrate removed to the initial substrate quantity, and results are compared against a reference brush tested in parallel, following the comparative principles embedded in ISO 20127 for powered devices and the general test framework of ISO 20126 for manual brushes.

Clinical Plaque Efficacy Trials

Clinical evaluation is conducted as a randomized, examiner-blinded study using either a crossover design with washout periods or a parallel-group design. After a lead-in phase with a standardized hygiene regimen, subjects abstain from oral hygiene for a defined period to allow plaque accumulation. A disclosing solution (such as erythrosine or a two-tone stain) visualizes the plaque, which is scored at baseline and after product use at the tooth, surface, and site level:

Turesky modification of the Quigley-Hein plaque index: a 0–5 scale scored at six sites per tooth, sensitive to early plaque accumulation.
Silness-Löe plaque index: a 0–3 scale integrating plaque quantity at the gingival margin.
Rustogi modification of the Navy plaque index: a site-specific binary system that highlights interproximal and gingival-area performance.

Statistical analysis compares mean plaque score reductions between test and reference products, with predefined non-inferiority or superiority margins and appropriate confidence intervals.

Chemical Plaque Inhibition Testing

For mouthrinses and active dentifrices, efficacy is measured through 24-hour plaque regrowth protocols in which subjects refrain from mechanical cleaning and use only the assigned rinse or slurry. Laboratory support includes ex vivo biofilm models on hydroxyapatite or saliva-coated surfaces, flow-cell biofilm cultivation, and antimicrobial susceptibility assays that corroborate the clinical anti-plaque effect.

Data Reporting

Final test reports document the test configuration, brushing or rinsing parameters, raw and calculated plaque scores or removal percentages, statistical treatment, and a clear conclusion on whether the product meets the claimed efficacy level. Accredited third-party laboratories issue these reports to support internal decision-making, regulatory submissions, and commercial documentation.

Applications

Plaque removal efficacy determination serves multiple functions across the product lifecycle:

Research and development: benchmarking prototypes against market-leading references and optimizing filament geometry, motion kinematics, or active ingredient concentrations.
Marketing claim substantiation: providing objective data behind claims such as "removes significantly more plaque" or "clinically proven plaque reduction."
Regulatory compliance and market access: supplying performance evidence required for product registration dossiers and conformity with ISO, EN ISO, and GB requirements.
Quality control: verifying batch-to-batch consistency of brush heads and finished devices through periodic comparative cleaning tests.
Competitive positioning: generating comparative data for retailer presentations, e-commerce platform documentation, and scientific publications.
Consumer safety assurance: confirming that enhanced plaque removal does not increase abrasivity or soft tissue irritation.

FAQ

Which standards govern dental plaque removal efficacy testing?

The core references are ISO 20126 for manual toothbrushes and ISO 20127 for powered toothbrushes, which define general requirements, test methods, and comparative cleaning performance principles. Dentifrices are covered by ISO 11609, while Chinese national standards such as GB 19342 and GB 30002 apply to domestic toothbrush products. Clinical protocols follow internationally recognized plaque indices such as the Turesky modification of the Quigley-Hein index.

What is the difference between in vitro and clinical plaque testing?

In vitro testing uses artificial plaque substrates and standardized brushing machines under tightly controlled mechanical parameters, delivering fast, reproducible, and low-cost comparative data. Clinical testing evaluates real human subjects under supervised use, capturing the combined effects of device design, technique, and compliance. In vitro results guide development, while clinical results substantiate consumer-facing efficacy claims.

How is plaque quantified during testing?

In the laboratory, plaque is quantified by gravimetric measurement of removed substrate, digital image planimetry of residual coverage, or surface profilometry. In clinical studies, a disclosing agent stains the plaque, and trained, calibrated examiners score disclosed areas using validated indices at six sites per tooth, with digital photography and image analysis increasingly used for objective documentation.

What are typical test conditions for in vitro brushing?

Standard conditions include a contact force of approximately 2.5 N, a defined number of brushing strokes or contact duration, a controlled stroke path, and a standardized substrate film thickness. Tests may be run dry or with a standardized dentifrice slurry, and a manual reference brush is tested in parallel to enable comparative evaluation.

Can test results be used to support advertising claims?

Yes. Reports from accredited third-party laboratories that describe statistically significant plaque reduction, whether in vitro or clinical, are widely used to substantiate marketing claims, satisfy e-commerce platform documentation requirements, and defend comparative statements in regulatory or dispute situations. Claim wording must accurately reflect the study design, endpoints, and statistical outcome.

How long does efficacy evaluation take?

In vitro brushing simulations are typically completed within a few weeks, including substrate preparation and repeat measurements. Clinical trials depend on their design: single-brushing studies may conclude in two to three weeks, while crossover plaque regrowth studies with washout periods usually require several weeks to a few months, including recruitment, calibration, and follow-up examinations.